Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- TURQUOISE-CPBIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4…
- TVEC-325Independent statistical analysis of Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TWO2DFUIndependent statistical analysis of Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TWPSIndependent statistical analysis of Long-Term Effects of Torso-Weighting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743312).
- Tx-TreatmentIndependent statistical analysis of Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- UCDCC#217Independent statistical analysis of Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- UGIH09067Independent statistical analysis of Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ULT-218Independent statistical analysis of Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03320096).
- UNCOVER-3Independent statistical analysis of A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01646177).
- UNIFIIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate…
- Unite-CNMIndependent statistical analysis of Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- UNIVERSEIndependent statistical analysis of Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure: primary endpoint results, effect estimate…
- upreACH-2Independent statistical analysis of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- URIDxEDIndependent statistical analysis of Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02957136).
- urochesterIndependent statistical analysis of Feasibility of the Memory and Attention Adaptation-Training Geriatrics Intervention in Older Cancer Survivors With Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- UVIndependent statistical analysis of Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VAST-DComplete statistical analysis of VAST-D, the phase 3 randomized trial of switching to bupropion-SR versus augmentation with bupropion-SR or aripiprazole for major depressive disorder, including remission, response, relapse, statistical methodology, safety, and…
- VECTORIndependent statistical analysis of Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VELVETIndependent statistical analysis of A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor…
- VENTUREIndependent statistical analysis of the VENTURE phase 3 trial evaluating dupilumab in patients with severe steroid-dependent asthma, including its randomized design, oral corticosteroid reduction endpoints, ANCOVA, logistic regression, missing-data methods, and reported…
- VERITASIndependent statistical analysis of A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal…
- VERITASIndependent statistical analysis of Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary: primary endpoint…
- VERTIS CVIndependent statistical analysis of VERTIS CV (NCT01986881): a stratified Cox non-inferiority analysis of ertugliflozin versus placebo for MACE with a 1.3 hazard-ratio margin, cLDA analyses of A1C change in glycemic sub-studies, secondary…
- VIBRANTIndependent statistical analysis of Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO): primary endpoint results, effect estimate with confidence…
- VICTORY-AFIndependent statistical analysis of Evaluation of the Phased Radio Frequency Ablation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693120).
- VIOLETIndependent statistical analysis of A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VIV-FIHIndependent statistical analysis of EasyCrossTM Device-Self-centering Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06412354).
- VOLVERIndependent statistical analysis of Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VOYAGEIndependent statistical analysis of Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VOYAGERIndependent statistical analysis of A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VPCIndependent statistical analysis of Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VRI01Independent statistical analysis of Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Wait and SeeIndependent statistical analysis of Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- WAVEIndependent statistical analysis of Durvalumab Long-Term Safety and Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04078152).
- WEARIT-FRIndependent statistical analysis of LifeVest Safety and Efficacy in Real Life Settings in France: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03319160).
- WH-PACTIndependent statistical analysis of Implementation of Women's Health Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039856).
- WHISPERIndependent statistical analysis of Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- WI223281Independent statistical analysis of Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Willow 3Independent statistical analysis of A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04194892).
- WISARDIndependent statistical analysis of Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With…
- WISEIndependent statistical analysis of Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- X-TOLEIndependent statistical analysis of A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- X-TRAPIndependent statistical analysis of Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- XEPADIndependent statistical analysis of An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ZEAL UNLOCKIndependent statistical analysis of A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ZEUSIndependent statistical analysis of Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ZODIACIndependent statistical analysis of OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ZUMA-1Independent statistical analysis of Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…